tradingkey.logo
搜索

Stereotaxis Inc

STXS
添加自选
1.790USD
+0.020+1.13%
收盘 07/02, 13:00美东报价延迟15分钟
174.50M总市值
亏损市盈率 TTM

Stereotaxis Inc

1.790
+0.020+1.13%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.13%

5天

+6.55%

1月

-4.79%

6月

-22.84%

今年开始到现在

-22.17%

1年

-18.64%

关键数据
1.780今开
1.820最高
229.52K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.24%换手率
1.770昨收
1.760最低
263.16K成交额
亏损市盈率静
12.15市净率
0.00%股息率 TTM
-43.48%ROA
3.59052周最高
0.48量比
-25.35M净利润
97.49M总股本
-0.2444每股收益TTM
1.36Beta
-266.26%ROE
1.70052周最低
3.38%振幅
60.31%毛利率
174.50M总市值
-1.88回报/风险
3.11%风险率

TradingKey Stereotaxis Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Stereotaxis Inc当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名99/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价4.12。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Stereotaxis Inc评分

相关信息

行业排名
99 / 204
全市场排名
242 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Stereotaxis Inc亮点

亮点风险
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
业绩高增长
公司营业收入稳步增长,连续3年增长20.94%
业绩增长期
公司处于发展阶段,最新年度总收入32.38M美元
估值合理
公司最新PE估值-7.32,处于3年历史合理位
机构加仓
最新机构持股49.70M股,环比增加4.31%

分析师目标

根据 4 位分析师
买入
评级
4.125
目标均价
+133.05%
涨幅空间

Stereotaxis Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Stereotaxis Inc简介

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
公司代码STXS
公司Stereotaxis Inc
CEOFischel (David Leo)
网址https://www.stereotaxis.com/

常见问题

Stereotaxis Inc(STXS)的当前股价是多少?

Stereotaxis Inc(STXS)的当前股价是 1.79。

Stereotaxis Inc的股票代码是什么?

Stereotaxis Inc的股票代码是STXS。

Stereotaxis Inc股票的52周最高点是多少?

Stereotaxis Inc股票的52周最高点是3.59。

Stereotaxis Inc股票的52周最低点是多少?

Stereotaxis Inc股票的52周最低点是1.70。

Stereotaxis Inc的市值是多少?

Stereotaxis Inc的市值是174.50M。

现在Stereotaxis Inc(STXS)的股票是买入、持有还是卖出?

根据分析师评级,Stereotaxis Inc(STXS)的总体评级为买入,目标价格为4.12。

Stereotaxis Inc(STXS)股票的每股收益(EPS TTM)是多少

Stereotaxis Inc(STXS)股票的每股收益(EPS TTM)是-0.25。